Parenteral Drugs (India) Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2022 | Dec 2021 | Sep 2021 |
|---|---|---|---|
| Revenue | 54.02 | 1.45 | 2.36 |
| Operating Expense | 7.66 | 4.67 | 5.62 |
| Net Profit | 23.81 | -34.52 | -33.61 |
| Net Profit Margin | 44.08 | -2,380.69 | -1,424.15 |
| Earning Per Share | 7.99 | -11.58 | -11.28 |
| EBIDTA | 50.96 | 6.49 | 6.19 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Mar 2022 |
|---|---|
| Revenue | 54.02 |
| Operating Expense | 7.66 |
| Net Profit | 23.81 |
| Net Profit Margin | 44.08 |
| Earning Per Share | 7.99 |
| EBIDTA | 50.96 |
| Effective Tax Rate | TBA |
Invest in Parenteral Drugs (India) Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|
| Total Revenue Annual | 12.17 | 31.87 | 33.21 |
| Operating Expenses Annual | 23.94 | 46.56 | 49.67 |
| Operating Profit Annual | -11.71 | -14.43 | -16.22 |
| Interest Annual | 125.44 | 109.96 | 96.05 |
| Depreciation | 17.33 | 17.35 | 69.12 |
| Net Profit Annual | -121.71 | -114.07 | -147.90 |
| Tax Annual | -32.76 | -27.66 | -33.49 |
| Particulars | Mar 2021 |
|---|---|
| Total Revenue Annual | 12.17 |
| Operating Expenses Annual | 23.94 |
| Operating Profit Annual | -11.71 |
| Interest Annual | 125.44 |
| Depreciation | 17.33 |
| Net Profit Annual | -121.71 |
| Tax Annual | -32.76 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.11 | 0.09 | 0.01 |
| Cash Flow from Operations | 125.32 | 112.37 | 455.79 |
| Cash Flow from Investing | 0.06 | 0.08 | 0.10 |
| Cash Flow from Financing | -125.44 | -112.43 | -455.79 |
| Cash Flow at the End | 0.06 | 0.11 | 0.09 |
| Particulars | Mar 2021 |
|---|---|
| Cash Flow at the Beginning | 0.11 |
| Cash Flow from Operations | 125.32 |
| Cash Flow from Investing | 0.06 |
| Cash Flow from Financing | -125.44 |
| Cash Flow at the End | 0.06 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|
| PBDIT Margin (%) | -96.14 | -45.28 | -48.84 |
| PBIT Margin (%) | -238.54 | -99.72 | -256.85 |
| PBT Margin (%) | -236.65 | -98.81 | -254.17 |
| Net PROFIT Margin (%) | -1,000.08 | -357.92 | -445.08 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -990.08 | -85.90 | -40.06 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.99 | 0.24 | 0.09 |
| Particulars | Mar 2021 |
|---|---|
| PBDIT Margin (%) | -96.14 |
| PBIT Margin (%) | -238.54 |
| PBT Margin (%) | -236.65 |
| Net PROFIT Margin (%) | -1,000.08 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -990.08 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.99 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|
| Fixed Assets Annual | 321.81 | 339.14 | 356.49 |
| Total Current Assets Annual | 67.35 | 66.74 | 66.58 |
| Non Current Assets Annual | 499.44 | 483.70 | 472.58 |
| Total Shareholders Funds Annual | -683.20 | -561.63 | -447.25 |
| Total Assets Annual | 566.79 | 550.44 | 539.16 |
| Particulars | Mar 2021 |
|---|---|
| Fixed Assets Annual | 321.81 |
| Total Current Assets Annual | 67.35 |
| Non Current Assets Annual | 499.44 |
| Total Shareholders Funds Annual | -683.20 |
| Total Assets Annual | 566.79 |
EPS (INR)
Expected
7.99
Reported
7.99
Surprise
0.00%
Dec 2021
EPS beaten by 0.00%
Sep 2021
EPS beaten by 0.00%
Jun 2021
EPS beaten by 0.00%
